AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer

British drugmaker AstraZeneca Plc said on Friday its immunotherapy cancer treatment Imfinzi has been granted a speedy review by the U.S. medicines watchdog for the treatment of a particularly aggressive type of lung cancer.

from Reuters: Health News https://ift.tt/2OtU9DI
https://ift.tt/xePdMM